These findings corroborate emerging evidence implicating NUCB2 in proliferative mechanisms across various cancer types, including nasopharyngeal carcinoma, bladder cancer, hepatocellular carcinoma, colorectal cancer and thyroid cancer [24, 25, 26, 27, 28]. Here, NUCB2 is linked to thyroid cancer.